Cargando…
Cystic fibrosis and COVID-19: Care considerations
The coronavirus disease 2019 (COVID-19) pandemic has demanded large scale changes in patient care. People with cystic fibrosis have unique considerations, including underlying lung disease and routine aerosolizing therapies, but there is insufficient evidence to create comprehensive practice guideli...
Autores principales: | Mirza, Alicia A., Rad, Elika J., Mohabir, Paul K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492163/ https://www.ncbi.nlm.nih.gov/pubmed/32953446 http://dx.doi.org/10.1016/j.rmcr.2020.101226 |
Ejemplares similares
-
Cystic fibrosis telemedicine in the era of COVID-19
por: Rad, Elika J, et al.
Publicado: (2022) -
COVID-19 in a Cystic Fibrosis Patient
por: Al Lawati, Adil, et al.
Publicado: (2023) -
Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care during the COVID-19 Pandemic
por: Ramos, Kathleen J., et al.
Publicado: (2020) -
COVID-19–Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report
por: Sher, Yelizaveta, et al.
Publicado: (2020) -
Biliary Atresia and Rare Concurrent Cystic Fibrosis Variant: Case Report and Management Considerations
por: Ang, Brandon, et al.
Publicado: (2023)